Disease burden in primary sclerosing cholangitis in the Netherlands: A long‐term follow‐up study

Our data quantify for the first time disease burden in terms of QALYs lost, clinical events, medical consumption, costs as well as work productivity loss, and show that all these are substantial and increase over time.